Nacol Biotech announced that it has raised tens of millions in a round of funding on August 11, 2023. The transaction included participation from new investors, SYoung Group Co., Ltd., Shike Venture Capital, Nanjing Chuangyi Longmen Furuida Venture Capital Partnership Enterprise (L.P.), a fund managed by Zhuhai Longmen Capital Management Co., Ltd., an investment arm and individual investors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.12 CNY | -2.45% | +6.58% | +14.70% |
04-24 | SYoung Group Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
04-23 | SYoung Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.70% | 1.05B | |
+0.62% | 261B | |
+19.64% | 19.93B | |
0.00% | 18.65B | |
+6.07% | 11.53B | |
-10.31% | 9.7B | |
+17.79% | 7.6B | |
+14.08% | 6.32B | |
+2.66% | 4.71B | |
-15.97% | 3.86B |
- Stock Market
- Equities
- 300740 Stock
- News SYoung Group Co., Ltd.
- Nacol Biotech announced that it has received funding from SYoung Group Co., Ltd., Shike Venture Capital, Zhuhai Longmen Capital Management Co., Ltd. and other investors